Trusted Resources: Education
Scientific literature and patient education texts
Diagnosis and Treatment of Transthyretin Cardiac Amyloidosis: Progress and Hope
source: Revista Española de Cardiología
year: 2017
authors: González-López E, López-Sainz Á, Garcia-Pavia P
summary/abstract:Cardiac amyloidosis is an infiltrative disorder caused by extracellular protein deposition. Transthyretin is a proamyloidotic protein that produces one of the most frequent forms of cardiac amyloidosis, either through mutations or a wild-type form (previously known as senile amyloidosis). Until very recently, diagnosis of transthyretin amyloidosis (ATTR) was very uncommon and histological confirmation was mandatory, making diagnosis of ATTR a real challenge in daily clinical practice. Moreover, the specific therapeutic options to alter the clinical course of the disease were very limited. However, advances in cardiac imaging and diagnostic strategies have improved recognition of ATTR.
In addition, several compounds able to modify the natural history of the disease are in the final phases of research, with promising results. Given that effective therapies are on the horizon, cardiologists should be well-versed in this disease and be familiar with its diagnosis and treatment. This review describes the broad clinical spectrum of ATTR in detail, as well as recent advances in the diagnosis and treatment of this condition.
organization: Hospital Universitario Puerta de Hierro, Spain; Universidad Francisco de Vitoria, SpainDOI: 10.1016/j.rec.2017.05.036
read more full text
Related Content
-
Amyloidosis and its Management: Amyloid NeuropathiesThe amyloid neuropathies are rare, rapid...
-
Pitfalls in Conducting Prospective Trials in Stage III Cardiac Amyloidosis – Experience from the REVEAL StudyVery few prospective clinical trials hav...
-
U.S. FDA Approves VYNDAQEL® and VYNDAMAX™ for Use in Patients with Transthyretin Amyloid Cardiomyopathy, a Rare a...Pfizer Inc. announced today that the U.S...
-
Cardiac Amyloidosis: An Update on Pathophysiology, Diagnosis, and TreatmentThe amyloidoses are a group of systemic ...
-
Liver Transplantation in Transthyretin Amyloidosis: Characteristics and Management Related to Kidney DiseaseOrthotopic liver transplantation (LT) wa...
-
Non-Liver Transplant Therapies for ATTR Amyloidosis 2022Non-Liver Transplant Therapies for ATTR ...
-
Amyloidosis Awareness: For Patients and Their Support Network, Including Physicians, Nurses and Medical Students [En...All the normal proteins in our body are ...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.